Clinical trial
DOLORISK: Understanding Risk Factors and Determinants for Neuropathic Pain - Chronic Neuropathy Following Chemotherapy
NCT02654691 is registered in ClinicalTrials.gov with Danish Pain Research Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- DOLORISK: Understanding Risk Factors and Determinants for Neuropathic Pain - Chronic Neuropathy Following Chemotherapy
- Lead sponsor
- Danish Pain Research Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2016
- Completion date
- July 1, 2019
- Enrollment
- 63 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.